Delivery Order SPE2DR25D2013-SPE2DR26F5QMH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,336.36 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,556.16 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction within the federal medical procurement system....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) under a firm fixed-price contract with a ceiling value of $2,983.84. This non-set-aside delivery order is scheduled for completion by October 30, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This contract was competitively awarded without any set-aside designation and is structured as a firm fixed price delivery order. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $1,171.80 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,945.20 for NovoLog 100 Unit/mL vials (10mL) with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,015.61 for NovoLog 100 Unit/mL vials (10 mL) on June 24, 2025, with completion targeted for June 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare...
- The Defense Logistics Agency has awarded a delivery order valued at $14,289.56 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract awarded on a competitive basis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $11,703.15 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL units). The award, issued on June 6, 2025, with completion targeted for June 9, 2025, utilizes firm fixed pricing and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city....
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QMHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,887.82 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on November 12, 2025, with completion expected by November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical supply fulfillment under the company's existing relationship with the Defense Logistics Agency's medical supply chain. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime vendor for federal pharmaceutical procurement, AmerisourceBergen supplies critical medical commodities including specialty medications, brand-name and generic drugs, and related medical supplies to support military healthcare programs and the Defense Health Agency. The company's federal contracting portfolio demonstrates consistent capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/12/25 |